Kasper van der Born

Statistics

Publications

Citations

H-Index

Active since

2002

Affiliations

Amsterdam UMC Location Vrije Universiteit Amsterdam(Current)

University Medical Center

Taiho Pharmaceutical (Japan)

Montefiore Medical Center

University Hospital and Clinics

Kasper van der Born is an author at Amsterdam UMC Location Vrije Universiteit Amsterdam specializing in pharmacology, chemotherapy, and cancer pharmacology.

Publications per year

2002–2009

Publications

Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin

M. Borner, Patrick Schöffski, Ronald de Wit et al. · European Journal of Cancer · 2002 · 319 citations

Pharmacy, Pharmacokinetics, Pharmacology +11

Phase I Study of Aerosolized SLIT Cisplatin in the Treatment of Patients with Carcinoma of the Lung

Bart P.H. Wittgen, Peter W.A. Kunst, Kasper van der Born et al. · Clinical Cancer Research · 2007 · 167 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

The Human Multidrug Resistance Protein MRP5 Transports Folates and Can Mediate Cellular Resistance against Antifolates

Peter R. Wielinga, Jan Hendrik Hooijberg, Sjöfn Gunnarsdottir et al. · Cancer Research · 2005 · 138 citations · Full text

Medicine, Biochemistry, Pharmacology +14

Gemcitabine uptake in glioblastoma multiforme: potential as a radiosensitizer

J. Sigmond, Richard J. Honeywell, Tjeerd J. Postma et al. · Annals of Oncology · 2008 · 90 citations · Full text

Medicine, Oncology, Pharmacology +14

Role of platelet-derived endothelial cell growth factor/thymidine phosphorylase in fluoropyrimidine sensitivity

Michiel de Bruin, T. van Capel, Kasper van der Born et al. · British Journal of Cancer · 2003 · 70 citations · Full text

Medicine, Oncology, Pharmacology +13

1–5 of 14